US Stock MarketDetailed Quotes
BPTSY BIOPHYTIS SPON ADR EACH REP 10 ORD(POST SPLIT)
- 3.050
- 0.0000.00%
15min DelayClose Dec 18 16:00 ET
2.24MMarket Cap-0.07P/E (TTM)
0.000High0.000Low2Volume3.090Open3.050Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)733.02KShares10.25052wk High-0.33P/B2.24MFloat Cap0.22452wk Low--Dividend TTM733.02KShs Float18.500Historical High--Div YieldTTM0.00%Amplitude0.224Historical Low0.000Avg Price1Lot Size
BIOPHYTIS SPON ADR EACH REP 10 ORD(POST SPLIT) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | (FY)Dec 31, 2018 | (Q2)Jun 30, 2018 | (Q1)Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 32.22%-12.87M | 12.78%-18.99M | -32.24%-21.77M | -14.47%-16.47M | -19.30%-14.38M | -94.24%-8.54M | -6.24%-1.82M | -38.16%-12.06M | -4.4M | -1.72M |
| Net income from continuing operations | 29.69%-17.03M | 22.29%-24.22M | -22.13%-31.16M | -34.68%-25.52M | -35.45%-18.95M | -132.27%-6.47M | -28.34%-3.73M | -22.61%-13.99M | ---2.79M | ---2.9M |
| Depreciation and amortization | 65.91%803K | 55.63%484K | 11.07%311K | 6.87%280K | 15.42%262K | 17.54%67K | 12.96%61K | 10.73%227K | --57K | --54K |
| Deferred tax | ---- | ---- | ---- | ---- | ---80K | ---- | ---- | ---- | ---- | ---- |
| Other non cash items | 5.49%1.31M | 69.36%1.24M | -90.81%731K | 436.48%7.96M | 777.51%1.48M | 97.29%3.93M | -44.84%-2.93M | -94.59%169K | --1.99M | ---2.03M |
| Change In working capital | 98.05%-26K | -232.18%-1.34M | 130.05%1.01M | -1,109.31%-3.36M | -70.76%333K | -68.31%-2.98M | 58.03%1.6M | 685.52%1.14M | ---1.77M | --1.02M |
| -Change in receivables | 519.60%1.67M | -130.69%-398K | 148.87%1.3M | -190.24%-2.65M | 314.36%2.94M | -83.94%-2.57M | 384.62%819K | -82.45%-1.37M | ---1.4M | --169K |
| -Change in payables and accrued expense | -82.50%-1.71M | -228.77%-937K | 59.46%-285K | 73.04%-703K | -200.31%-2.61M | -5.07%-394K | -8.27%776K | 189.86%2.6M | ---375K | --846K |
| -Change in other current assets | --14K | --0 | 50.00%-2K | ---4K | --0 | ---19K | --9K | ---17K | --0 | --0 |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---72K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 32.20%-12.87M | 20.20%-18.99M | -144.23%-23.8M | 35.27%-9.74M | -24.83%-15.05M | -125.33%-5.33M | -34.31%-5.03M | -38.16%-12.06M | ---2.37M | ---3.75M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 2,276.47%370K | -100.14%-17K | 195.65%12.16M | -4,473.02%-12.71M | -167.31%-278K | -1,400.00%-270K | -116.67%-13K | 14.75%-104K | -18K | -6K |
| Net intangibles purchase and sale | -56.03%-220K | 59.01%-141K | -60.75%-344K | 24.11%-214K | -149.56%-282K | -1,200.00%-273K | -55.56%-14K | 11.72%-113K | ---21K | ---9K |
| Net investment purchase and sale | 375.81%590K | -99.01%124K | 200.00%12.5M | ---12.5M | --0 | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 2,276.47%370K | -100.14%-17K | 195.65%12.16M | -4,473.02%-12.71M | -167.31%-278K | -1,400.00%-270K | -116.67%-13K | 14.75%-104K | ---18K | ---6K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 14.54%7.03M | -79.36%6.13M | 35.36%29.72M | 201.64%21.95M | 7.49%7.28M | -178.51%-380K | 2,263.53%1.84M | -73.60%6.77M | 484K | -85K |
| Net issuance payments of debt | -95.35%345K | -56.03%7.42M | 263.95%16.88M | 1.24%4.64M | -36.36%4.58M | -177.46%-378K | 2,752.94%2.26M | -73.95%7.2M | --488K | ---85K |
| Net common stock issuance | --5.54M | --0 | -29.39%16.58M | --23.49M | --0 | ---- | ---- | --0 | ---- | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 35,666.67%2.15M | -99.19%6K | -34.51%742K | --1.13M | --0 | ---- | ---- | --0 | ---- | ---- |
| Net other financing activities | 13.77%-545K | 83.91%-632K | 41.15%-3.93M | -276.75%-6.68M | 1,393.49%3.78M | --158K | ---208K | 85.71%-292K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 14.56%7.03M | -79.36%6.13M | 35.36%29.72M | 201.64%21.95M | 7.49%7.28M | -178.67%-380K | 2,263.53%1.84M | -73.60%6.77M | --483K | ---85K |
| Net cash flow | ||||||||||
| Beginning cash position | -53.80%11.05M | 309.20%23.93M | -7.73%5.85M | -56.01%6.34M | -27.45%14.41M | -30.45%11.15M | -27.45%14.41M | 547.65%19.86M | --16.04M | --19.86M |
| Current changes in cash | 57.45%-5.48M | -171.18%-12.87M | 3,694.43%18.08M | 93.75%-503K | -49.37%-8.05M | -214.80%-5.98M | 16.45%-3.21M | -132.09%-5.39M | ---1.9M | ---3.84M |
| Effect of exchange rate changes | -200.00%-9K | -200.00%-3K | -107.69%-1K | 172.22%13K | 70.49%-18K | 320.00%33K | -450.00%-49K | -1,933.33%-61K | ---15K | --14K |
| End cash Position | -49.62%5.57M | -53.80%11.05M | 309.20%23.93M | -7.73%5.85M | -56.01%6.34M | -63.13%5.21M | -30.45%11.15M | -27.45%14.41M | --14.12M | --16.04M |
| Free cash flow | 31.55%-13.09M | 20.75%-19.13M | -142.43%-24.14M | 35.06%-9.96M | -25.99%-15.33M | -134.79%-5.6M | -34.36%-5.04M | -37.44%-12.17M | ---2.39M | ---3.75M |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data